What is an octreotide scan? Nuclear medicine uses radioactive materials to diagnose or treat diseases. An octreotide scan is one…Read more
Referral for a SPECT-CT scan is usually done after consultation between the nuclear medicine specialist and the referrer. The nuclear medicine specialist may consider the SPECT-CT to be helpful in delineating pathology when standard planar gamma camera imaging is difficult to interpret.
This study may not be suitable for pregnant women. The benefit versus risk should be discussed with the nuclear medicine specialist.
Women who are breastfeeding and people who are the primary or sole carer for small children may need to make special preparations after the test to stop breastfeeding for a short time and to avoid close contact with young children due to the small amount of radioactivity released for a while after the test. Patients should discuss this with their referring doctor or the nuclear medicine practice where they will have the test for details. See nuclear medicine for further information about the precautions to take with nuclear medicine studies for breastfeeding patients and those in close contact with children.
Relative contraindications include patients who exceed the weight limit for the SPECT or CT scanner table (this varies depending on the machine but usually at least 150 kilograms). It is best to check with the technologist staff at your nuclear medicine department first. Patients must be capable of voluntarily staying still.
There are no adverse effects of a SPECT-CT scan.
Referral for SPECT-CT is usually done after consultation between the reporting nuclear medicine specialist and the referrer. The nuclear medicine specialist may consider the SPECT-CT to be helpful in delineating pathology when standard planar gamma camera imaging is difficult to interpret.
SPECT-CT imaging involves the acquisition of a low dose, non-contrast, non-diagnostic CT (computed tomography) scan immediately prior to SPECT (single photon emission computed tomography) imaging, which uses a rotating gamma camera. It is usually performed in nuclear medicine as an adjunct to standard single plane, gamma camera imaging as a useful problem solving tool for interpretation of difficult imaging.
Post-acquisition fusion of the CT component of the study with SPECT enables more precise anatomical localisation of radiopharmaceutical uptake. The CT also enables correction for artefact which results from some of the emitted ionising radiation travelling through and being attenuated in the patient’s body tissues prior to being detected on the rotating gamma camera.
To enable accurate image fusion, patients must be able to stay still for the duration of the imaging (usually 30-40 minutes). Risks from the additional radiation required from the low dose CT scan are very minimal, notably the dosage using standard low dose CT technique is around 20-25% that of a comparable standard radiology diagnostic CT scan.
The low dose CT is usually accurate enough to detect gross structural abnormalities such as degenerative arthropathy of the joints or spine, large, multi centimetre soft tissue masses, and viscera. Given the lower radiation dose and absence of IV contrast it is not diagnostic for more subtle pathology such as small metastases, non-displaced fractures or intra-abdominal lymph nodes. Notably, whilst anatomic localisation is improved with SPECT-CT fusion, the inherent resolution of the nuclear medicine component of the imaging is not changed.
Page last modified on 26/7/2017.
RANZCR® is not aware that any person intends to act or rely upon the opinions, advices or information contained in this publication or of the manner in which it might be possible to do so. It issues no invitation to any person to act or rely upon such opinions, advices or information or any of them and it accepts no responsibility for any of them.
RANZCR® intends by this statement to exclude liability for any such opinions, advices or information. The content of this publication is not intended as a substitute for medical advice. It is designed to support, not replace, the relationship that exists between a patient and his/her doctor. Some of the tests and procedures included in this publication may not be available at all radiology providers.
RANZCR® recommends that any specific questions regarding any procedure be discussed with a person's family doctor or medical specialist. Whilst every effort is made to ensure the accuracy of the information contained in this publication, RANZCR®, its Board, officers and employees assume no responsibility for its content, use, or interpretation. Each person should rely on their own inquires before making decisions that touch their own interests.